You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events

  • Technology appraisal guidance
  • Reference number: TA210
  • Published:  15 December 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

TA210 Vascular disease - clopidogrel and dipyridamole: GE decision paper September 2013

TA210 Vascular disease - clopidogrel and dipyridamole: GE decision paper September 2013 TA210 Vascular disease - clopidogrel and dipyridamole: GE decision paper September 2013
23 September 2013
(123.81 Kb 36 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 18 September 2013

Back to top